Advertisement

Topics

Rigontec purchased by Merck for $554M

06:00 EDT 7 Sep 2017 | SmartBrief

Rigontec was acquired by Merck for up to $554 million.  -More

Original Article: Rigontec purchased by Merck for $554M

NEXT ARTICLE

More From BioPortfolio on "Rigontec purchased by Merck for $554M"

Quick Search
Advertisement
 

Relevant Topic

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...